-
EP3821906
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3821906
| EP3821906 - VACCINE AGAINST RSV COMPRISING MODIFIED F POLYPEPTIDE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.04.2021 Database last updated on 08.06.2024 | Most recent event Tooltip | 01.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Janssen Vaccines & Prevention B.V. Archimedesweg 4 2333 CN Leiden / NL | [2021/20] | Inventor(s) | 01 /
LANGEDIJK, Johannes Petrus Maria Archimedesweg 4-6 2333 CN Leiden / NL | 02 /
ROYMANS, Dirk André Emmy c/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [2021/20] | Representative(s) | Beslier, Victor Janssen Vaccines & Prevention B.V. Archimedesweg 4-6 2333 CN Leiden / NL | [N/P] |
| Former [2021/20] | Manten, Annemieke, et al Janssen Vaccines & Prevention B.V. Archimedesweg 4-6 2333 CN Leiden / NL | Application number, filing date | 20199540.4 | 07.07.2016 | [2021/20] | Priority number, date | EP20150175647 | 07.07.2015 Original published format: EP 15175647 | [2021/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3821906 | Date: | 19.05.2021 | Language: | EN | [2021/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.04.2021 | Classification | IPC: | A61K39/155, A61K39/12, A61P31/14 | [2021/20] | CPC: |
A61K39/12 (EP,CN,IL,US);
A61K39/155 (EP,IL,KR,US);
A61P11/00 (CN,IL,KR);
A61P31/14 (EP,CN,IL,US);
C07K14/005 (CN,IL,US);
C07K2319/00 (CN,IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/20] | Title | German: | IMPFSTOFF GEGEN RSV UMFASSEND EINES MODIFIZIERTEN F POLYPEPTIDE | [2021/20] | English: | VACCINE AGAINST RSV COMPRISING MODIFIED F POLYPEPTIDE | [2021/20] | French: | VACCIN CONTRE LE VSR COMPRENANT POLYPEPTIDE F MODIFIÉE | [2021/20] | Examination procedure | 01.10.2020 | Examination requested [2021/20] | 10.12.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 09.02.2022 | Amendment by applicant (claims and/or description) | Parent application(s) Tooltip | EP16736161.7 / EP3319633 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 09.02.2022 | Request for further processing filed | 09.02.2022 | Full payment received (date of receipt of payment) Request granted | 18.02.2022 | Decision despatched | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 09.02.2022 | Request for further processing filed | 09.02.2022 | Full payment received (date of receipt of payment) Request granted | 18.02.2022 | Decision despatched | Fees paid | Renewal fee | 01.10.2020 | Renewal fee patent year 03 | 01.10.2020 | Renewal fee patent year 04 | 01.10.2020 | Renewal fee patent year 05 | 15.07.2021 | Renewal fee patent year 06 | 16.06.2022 | Renewal fee patent year 07 | 14.06.2023 | Renewal fee patent year 08 | 30.05.2024 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO03040178 (BIOTA HOLDINGS LTD [AU], et al); | [XI]US2014271699 (KWONG PETER [US], et al); | [XI]WO2014160463 (US HEALTH [US], et al); | [AD]WO2014174018 (CRUCELL HOLLAND BV [NL]); | [XDI]WO2014202570 (CRUCELL HOLLAND BV [NL]); | by applicant | WO9003184 | WO9014837 | US5057540 | WO9609378 | WO9611711 | WO2004004762 | WO2005002620 | WO2012006596 | WO2014174018 | WO2014202570 |